Joern-Hendrik Weitkamp
Last active: 4/16/2021

Safety and effectiveness of meropenem in infants with suspected or complicated intra-abdominal infections.

Cohen-Wolkowiez M, Poindexter B, Bidegain M, Weitkamp JH, Schelonka RL, Randolph DA, Ward RM, Wade K, Valencia G, Burchfield D, Arrieta A, Mehta V, Walsh M, Kantak A, Rasmussen M, Sullivan JE, Finer N, Rich W, Brozanski BS, van den Anker J, Blumer J, Laughon M, Watt KM, Kearns GL, Capparelli EV, Martz K, Berezny K, Benjamin DK, Smith PB, Meropenem Study Team
Clin Infect Dis. 2012 55 (11): 1495-502

PMID: 22955430 · PMCID: PMC3491861 · DOI:10.1093/cid/cis758

MeSH Terms (11)

Anti-Bacterial Agents Cohort Studies Critical Illness Female Humans Infant Infant, Newborn Intraabdominal Infections Male Meropenem Thienamycins

Connections (1)

This publication is referenced by other Labnodes entities:

Links